AUG 29, 2020
end channels
New Users Please Click to Register
Renew or Upgrade your Existing  Account
facebook link
HDCN Facebook
off Symposia
Hypertension, Dialysis and Clinical Nephrology
VBOOTHS :  Google :  PubMed  :   Scholar  :   K/DOQI :  UpToDate :  eGFR
Slides/audio/handouts:    RRI-2020  :  ISHD-HDU-2019  :  RRI-2019  :  Harvard-2018  :  RRI-2018  :  Harvard-2017  :  ISHD-HDU-2017  :  RRI-2017  :  ISHD-HDU-2016  :  RRI-2016  :  ISHD-HDU-2015  :  Brigham-2015  :  RRI-2015  :  ISHD-HDU-2014  :  Brigham-2014  :  ISHD-India-2014  :  RRI-2014  :  Brigham-2013  :  ISHD Shanghai-2013  :  ASH-2013  :  ADC-2013 (audio)  :  ASDIN-2013  :  RRI-2013  :  ISHD-HDU-Chicago-2012/14  :  Brigham-2012  :  ASH-2012  :  ADC-2012 (audio)  :  NANT-2012  :  ASDIN-2012  :  RPA-2012  :  RRI-2012  :  Brigham-2011  :  ASH-2011  :  ADC-2011  :  NANT-2011  :  ASDIN-2011  :  RPA-2011  :  RRI-2011  :  Fistula First-2010  :  ADC-2010  :  NANT-2010  :  ASDIN-2010  :  RRI-2010  :  RPA-2010  :  Network9,10-2008  : 
TalksbyDate   Search HDCN:  FreeTalks   (key):   Articles :  Abstracts :  Audiofiles :  SlideTalks :  LegacyTalks  
what new
free ISHD Hemodialysis University Chicago (2012-2014)
free ISHD Hemodialysis University Shanghai 2013
free ISHD Hemodialysis University Chicago (2014)
free ISHD Hemodialysis University India (2014)
ishd ISHD Hemodialysis University Chicago (2015)
ishd ISHD Hemodialysis University Chicago (2016)
ishd ISHD Hemodialysis University Chicago (2017)
ishd ISHD Hemodialysis University Chicago (2019) incl. free CME/CEU !


Hemodialysis University 2019   free
Flash or IPAD slide/audio
International Society for Hemodialysis;
Chicago, September 2019


What’s New in Anemia Management for Hemodialysis?
Jay Wish, MD




Hemodialysis University 2019   key
Flash or IPAD slide/audio
International Society for Hemodialysis;
Chicago, September 2019


Aspirin and Other Anti-platelet Agents and Vascular Access
Anil Agarwal, MD

Dosing of Advanced Anti-platelet drugs in coronary syndromes in HD pts
Anil Agarwal, MD

Modeled Daily Absorbable Phosphorus and Protein Catabolic Rate
John Daugirdas, MD



Harvard Intensive Review of Nephrology 2018   key
Flash or IPAD slide/audio
Harvard Medical School; Boston, MA; August 2018


Poisonings and intoxications. What a Nephrologist now Needs to Know?
Timothy B Erickson MD






Advances in Chronic Kidney Disease 2020   key
Flash or IPAD slide/audio
Renal Research Institute; Los Angeles, CA; January, 2020


Welcome/Program Overview
Peter Kotanko, MD

High quality PD: how can it be achieved?
Issac Teitelbaum, MD

Why should Uremic Pruritus (UP) and Restless Legs Syndrome (RLS) be diagnosed and treated?
Mark Unruh MD

Intradialytic hypotension: mechanisms and outcome
Jeroen Kooman, MD



Hypertension, Cardiovascular
Continuous glucose monitoring and glucose control
Clinic vs. ambulatory BP measures
Canagliflozin outcomes by GFR ranges
Catheter-based denervation works
Heparin vs. enoxaparin to prevent embolism in morbidly obese
Gastric bypass surgery and renal risk reduction
ARBs vs. CCBs: BP lowering profiles
High BP ups renal cancer risk
BP lowering good for a. fib risk
ISH 2020 BP guidelines
Quick thrombolysis good for acute ischemic stroke
Bardoxolone methyl improves GFR in type 2 DM
Digital management of HTN
Unrecognized primary aldo
Self-measured BP monitoring at home: AMA and AHA
Serum aldo and coronary calcium
Monitoring anti-HTN drug blood levels

CKD, Dialysis
Coffee consumption and kidney function
KDOQI comments on KDIGO latest hep C guidelines
COVID-19 and acute kidney injury in China
COVID-19 and CV disease
COVID-19 and inpatient HD unit policy
Initial drop in BP not harmful in HTN treatment
Low sodium dialysate and LVH
IV iron and infection risk
Restricted protein diet and keto-analogues good
Potato cooking methods to lower K content
Stopping RAS blockers in advanced CKD not good
Difelikefalin for itching
Residual urine output and mortality
Early RRT in AKI not better
Beta-blockers lower death rate in advanced CKD
Residual kidney function and protein-bound solutes
Overcoming barriers to home HD
Pericarditis constrictiva and allograft non-function
Management of COVID-19 CV syndrome
Serum bicarb and CKD progression in kids
Intradialytic hypotension and arrhythmia risk
Opioids and gabapentinoids up hip fx. risk
New approaches to AV access creation
Dialysate sodium measurement overestimate and analyzer setting
Allopurinol does not slow CKD progression
Dietary fiber and CV risk
GFR and anabolic steroid use
Buttonhole cannulation ups infection risk
Multidisciplinary medication management good
Itching as an endpoint in HD trials
Kt/V with infrequent postdialysis BUN measurement
AV fistula ligature and high-output heart failure
Leg vein thrombosis with COVID-19
History of hemodialysis in China (KEY)
Roxadustat vs. darbepoetin
Prebiotics, probiotics and synbiotics
Tablet-based patient symptom reporting
Early RRT not better (another one)
Dietary zinc and aorta calcification
Low plasma zinc levels and CKD progression

Clinical Nephrology
Eculizumab in kidney transplant results
Regulatory cell Rx in kidney transplant
Magnesium inhibits calciprotein particles
Different anti-HTN drugs in kidney transplant
Eculizumab in lupus TMA
Inapproriate diuresis with COVID-19
Ravulizumab in atypical HUS
Managemnt of hyperkalemia in HD
Hypochloremia vs. hyponatremia and outcomes in CKD
GFR in healthy aging
AKI in pts. with COVID-19

ASN abstracts

key This update's selected ASN 2019 abstracts

Baseline diastolic BP and intensive BP lowering; Pulse pressure and outcomes in the LURIC study; Impedance cardiography individualized BP treatment; LDL-cholesterol vs. outcomes by CKD stage; Serum triglycerides and outcomes by level of proteinuria.

CKD, Dialysis
Asymptomatic cerebral microbleeds; Citrate dialysate does not harm patients; TMAO and outcomes in HD patients; Monitoring Kt/V with infrequent postdialysis BUN; Plasma viscosity can explain lower in vivo K0A; Efficacy and safety of expanded HD; PROMs with expanded HD; Rinsing pre-processed dialyzers before a dialysis session; Tablo HD system in an acute hospital setting; Incenter nocturnal HD outcomes in an LDO setting; Adjusting HCO3 during frequent nocturnal HD; Frequency of HD in nursing homes vs. outcome; Home HD vs. ethnic group and payment eligibility; Point-of-care ultrasound and PD catheter-related infection; Peritoneal function vs. biocompatibility of PD solution; Morepenem pharmacokinetics in PD; Sleep vs mortality in HD; Pseudo-low bicarbonate blood levels and serum triglycerides; CAC vs. CKD progression; EKG findings vs. outcome in HD; Apabetalone and CV risk; Uremic pericarditis in CKD; Thyroid status vs. kidney function.

Clinical Nephrology, Transplantation
Glomerular hyperfiltration ups dementia risk; Equation to estimate urinary flow rate; Acidification effects of medication; Alkalinization effects on ECF; Calcium vs. sodium polystyrene sulfonate; Sodium zirconium cyclosilicate and hyperkalemia in ESRD; Hyperkalemia and CKD progression; Benefits of patiromer; Relapse after eculizumab withdrawal; Cyclophosphamide plus cyclosporine for membranous GN; Rituximab, cyclophosphamice, and prednisone for membranous GN; Rituximab treatment for membranous; C3 inhibition with APL-2; Creatinine fluctuation in lupus pts. during remission; Lupus pts. with low-level proteinuria; TMA in lupus nephritis; Relapse risk in lupus after stopping MMF; Polycystic kidney disease by race/ethnicity; Cytomegalovirus prevention strategies; Med adherence in transplant patients with once-daily dosing.

 (Kidney Week 2019...)

News     Hit reload / refresh
RSS  Click on RSS for details of each news story.
Updated: June 15, 2020 (Jun15)
Jun15 Dr. Burton (Bud) D. Rose, in memoriam
Mar13 Guidance from CDC re COVID-19 preventive practices in HD units
Mar01 ASN FAQ sheet re COVID-19 in dialysis facilities
Oct23 Akebia sues CMS for denying coverage for Auryxia under Medicare Part D
Oct23 Taking antihypertensives at bedtimes lowers cardiovascular risk.
Aug29 ISHD Hemodialysis University on September 22-23, in Chicago
Aug14 Pretomanid, bedaquiline and linezolid combo FDA approved for resistant TB.
Aug13 SPRINT substudy shows that intensive BP control lowers rate of white matter brain lesions.
Aug13 Dog dies after swim in Georgia lake with blue-green algae bloom
Jul19 Full text of President Trump Executive Order re kidney disease (PDF)
Jul11 Trump's advancing kidney care initiative
Jul11 KidneyX phase 1 winners announced (old news but important - Apr. 29th)
Jul09 Predicing serum K from the EKG trace measured by an Apple watch.
Jul02 HIV infection cured in mice using CRISPR technology.
Jul01 Low grade E. Coli urinary tract infections picked up by DNA testing of urine.
May09 Fournier gangrene of the genitals linked to SGLT2 inhibitor drugs
Apr29 Immune cell test identifies patients with chronic fatigue syndrome.
Apr06 Candida auris infections spreading rapidly across the globe.
Apr03 Rehydrating with soft drinks after exercise increases AKI injury markers
Feb19 Universal flu vaccine on the near horizon
General Advances Emphasis
featured articles
key The history of hemodialysis in China
Drs. Bi, Mu, Tang, and their colleagues give an overview of the pioneers of dialysis in China, and some relatively recent statistics showing how rapidly dialysis is progressing in that country; in the July issue of Hemodial Int (more...)

Seminars in Dialysis
key Incorporating patient-reported outcomes (PROs) into dialysis policy: Current initiatives, challenges, and opportunities
Dr. Umeukej and colleagues discuss practical and effective ways of collecting PRO data in dialysis patients and acting upon it; in the Jan/Feb issue of Seminars in Dialysis. (more...)

Seminars in Dialysis
key Antibiotic locks for the treatment of catheter-related blood stream infection: Still more hope than data
Dr. Labriola reviews the evidence, and which treatments are worth trying now; in the Sep/Oct issue of Seminars in Dialysis. (more...)

Seminars in Dialysis
key Addressing myths about exercise in hemodialysis patients
Drs. Wilund, Jeong, and Greenwood talk about the pros and cons and practical issues related to setting up exercise programs for dialysis patients; in the July/August issue of Seminars in Dialysis. (more...)

Seminars in Dialysis
key The promise of bioimpedance for volume management in American dialysis patients: An unfulfilled opportunity
Dr. Kotanko discuses various methods volume management, focusing on bioimpedance, which is widely used throughout Europe; in the May/June issue of Seminars in Dialysis. (more...)

Seminars in Dialysis
key Evaluating CKD/ESRD patient with hepatitis C infection: How to interpret diagnostic testing and assess liver injury Drs. Cottone and Bhamidimarri discuss how conventional tests of liver involvement in hepatitis C need to be interpreted in patients on dialysis; This is one of many articles focusion on HCV diagnosis and treatment in a special Mar/Apr issue of Seminars in Dialysis. (more...)

Seminars in Dialysis
key PTH assays in dialysis patients: Practical considerations Drs. Soliman, Hassan, Yaseen and their colleagues review the different type of PTH assays as well as their reliability; in the Jan/Feb issue of Seminars in Dialysis. (more...)

Seminars in Dialysis
key Ultrafiltration rate in conventional hemodialysis: Where are the limits and what are the consequences? Drs. Slinin, Babu, Ishani and their colleagues discuss the evidence that a high UF rate is bad, and also guide us as to what an appropriate target might be; in the Nov/Dec issue of Seminars in Dialysis. (more...)

key Online measurement of hemodialysis adequacy using effective ionic dialysance of sodium - a review of its principles, applications, benefits, and risks
Drs. Aslam, Saggi, Salifu, and colleagues discuss the basics of the concept of sodium conductivity monitoring of dialyzer clearance, as well as the potential applications and pitfalls; in the October issue of Hemodial Int (more...)

Seminars in Dialysis
key Vaccination practices in dialysis patients: A narrative review Drs. Kosmadakis and their colleagues guide us regarding what vaccinatinons are officially recommended, vs. others that may simply be a good idea to give; in the Sept/Oct issue of Seminars in Dialysis. (more...)

key Management of pain in end-stage renal disease patients: Short review
Drs. Raina, Krishnappa, and Gupta discuss the difficult topic of measuring and managing pain in the context of the current opioid use epidemic in the United States; in the July issue of Hemodial Int (more...)

Seminars in Dialysis
key Beta blockers in patients with end-stage renal disease - Evidence-based recommendations Drs. Weir and Herzog discuss the evidence base regarding when use of beta-blockers may be advantageous in patietns with ESRD, and when one should use alternative medications; in the June issue of Seminars in Dialysis. (more...)

key The nature, consequences, and management of neurological disorders in chronic kidney disease
Drs. Jabbari and Vaziri review the numerous way in which neurologic issues can arise in dialysis patients; in the April issue of Hemodial Int (more...)

Seminars in Dialysis
key Business of dialysis and the role of the medical director Dr. Paul Scheel reviews the responsibilities of a dialysis unit medical director are; in the Mar/Apr issue of Seminars in Dialysis. (more...)

key Management of hepatitis C virus infection in patients with advanced kidney disease
Dr. Craig Gordon has put together a wonderful supplement dealing with all aspects of hepatitis C virus management in CKD. The articles are open access and free CME and CNE credits are available; in the April issue of Hemodial Int (more...)

Seminars in Dialysis
key When and how can nephrologists treat hepatitis C virus infection in dialysis patients? In a most timely article, Davis, Chute, Chung and their colleagues review the various potential indications for the use of the marvelous new hepatitis C drugs in dialysis patients. in the Jan/Feb issue of Seminars in Dialysis. (more...)

key Subcutaneous defibrillators for dialysis patients
In this high-risk population for arrhythmias, it is logical to try the use of subcutaneous defibrillators. Tushar Vachharajani and colleagues review the potential indications as well as problems; in the January issue of Hemodial Int (more...)

free   SUMMARIES of Recent Slide/Audio Symposia in reverse chronological order

key   ISHD Hemodialysis University (2019-Chicago) -- (2017-Chicago) -- (2016-Chicago) -- (2015-Chicago) -- (2014-India) -- (2014-Chicago) -- (2013-Shanghai) -- (2012-Chicago)
key   Advances in CKD (Renal Research Institute) (2020) (2019) (2018) (2017) (2016) (2015) (2014) (2013) (2012) (2011) (2010) (2009)
free   Kidney Disease in Type 2 Diabetes: Disease Progression and Emerging Therapies
Philip Raskin, MD; Jennifer Marks, MD, Jerry Yee, MD, Mark Molitch, MD. (2011)
key   The Harvard Intensive Review of Nephrology (Brigham Renal Board Review) Course: Selected Lectures (2018) -- (2017) -- (2015) -- (2014) -- (2013) -- (2012) -- (2011)
key   American Society of Hypertension (2013)   (2012)   (2011)
key   Renal Physicians Association (2012) (2011) (2010) (2009)
key   American Society for Diagnostic and Interventional Nephrology (ASDIN) (2013) (2012) (2011) (2010) (2009)
free   Fistula First (2010)
key   Annual Dialysis Conference (audiofiles) (2012)   (2011) (2010) (2009)
key   National Association of Nephrology Technologists (NANT) (2012) (2011) (2010) (2009)
key   American Society for Nephrology Renal Week (2009) (2008) (2007)
key   American Society for Nephrology Board Review Course (2008) (2007)
key   American Society for Nephrology Renal Week (audiofiles) (2009) (2008) (2007)
key   Preparing for the New Medical Director Responsibilities (Network 9/10 - RPA Special Symposium)



Site Description:
Hypertension, Dialysis, and Clinical Nephrology provides up-to-date, selected information on renal disorders and their treatment (hemodialysis, peritoneal dialysis), and about hypertension, dialysis, and clinical nephrology topics.
Hypertension, Dialysis, and Clinical Nephrology is a place for physicians and nurses who treat patients with kidney or renal disease. Here physicians and nurses can find answers to frequently asked hypertension, dialysis, and nephrology questions (FAQ), pointers to recent review articles, and summaries of hot new hypertension, dialysis, and nephrology papers, abstracts, and meeting presentations. Also, information about medical products, devices, services, and drugs pertaining to hypertension, dialysis, and clinical nephrology are provided, as is a list of links to relevant hypertension / dialysis / transplantation organizations, medical provider networks, and databases. Much of the information presented is collected from a distinguished editorial board composed of specialists in the field of kidney or renal disease.

The information at this server is provided with the understanding that the publisher, authors, and advisors are not rendering medical or medical professional services. Medicine is a rapidly changing area, and efforts have been made to provide information that is medically correct at the time of publication. However, there may be mistakes, both typographical and in content. The material provided should be used only as a general guide and not the ultimate source of information. The material should not be used to form the basis of personal or professional decisions. The authors, advisors, and publisher shall have neither liability not responsibility to any person or entity with respect to any loss or damage alleged to be caused directly or indirectly by the information presented on this server.

Copyright statement:
Disclaimer: The reader is responsible for discerning the validity, factuality or implications of information posted here. The content of posts on this site, including but not limited to links to other web sites, are the expressed opinion of the original poster and are in no way representative of or endorsed by the owners or administration of this website. The posts on this website are the opinion of the specific author and are not statements of advice, opinion, or factual information on behalf of the owner or administration of HDCN or Medtext, Inc. This site is provided "as is" without warranty of any kind, either expressed or implied. You should not assume that this site is error-free or that it will be suitable for the particular purpose which you have in mind when using it. In no event shall hdcn.com or Medtext, Inc. be liable for any special, incidental, indirect or consequential damages of any kind, or any damages whatsoever, including, without limitation, those resulting from loss of use, data or profits, whether or not advised of the possibility of damage, and on any theory of liability, arising out of or in connection with the use or performance of this site or other documents which are referenced by or linked to this site. Fair Use Notice: This site may contain copyrighted material the use of which has not always been specifically authorized by the copyright owner. Users may make such material available in an effort to advance awareness and understanding of issues relating to civil rights, economics, individual rights, international affairs, liberty, science & technology, etc. We believe this constitutes a 'fair use' of any such copyrighted material as provided for in section 107 of the US Copyright Law. In accordance with Title 17 U.S.C.Section 107, the material on this site is distributed to those who have expressed a prior interest in receiving the included information for research and educational purposes. In accordance with industry accepted best practices we ask that users limit their copy / paste of copyrighted material to the relevant portions of the article you wish to discuss and no more than 50% of the source material, provide a link back to the original article and provide your original comments / criticism in your post with the article. Please remember YOU are responsible for what YOU post on the internet and YOU could be sued by the original copyright holder if you do not honor these rules. If you are a legal copyright holder or a designated agent for such and you believe a post on this website falls outside the boundaries of "Fair Use" and legitimately infringes on yours or your clients copyright we may be contacted concerning copyright matters at: Medtext, Inc. 15W560 89th Street Burr Ridge, IL 60527 tel: 630-325-3276 email: editor -at sign- hdcn.net If you require a courier address please send a fax or email and we will provide you with the required information. In accordance with section 512 of the U.S. Copyright Act our contact information has been registered with the United States Copyright Office. "Safe Harbor" noticing procedures as outlined in the DMCA apply to this website concerning all 3rd party posts published herein. If notice is given of an alleged copyright violation we will act expeditiously to remove or disable access to the material(s) in question. It is our strict policy to disable access to accounts of repeat copyright violation offenders. We will also ban the IP address of repeat copyright violators from future posting on this website with or without a registered account. All 3rd party material posted on this website is copyright the respective owners / authors. hdcn.com makes no claim of copyright on such material. For more information please visit: http://www.law.cornell.edu/uscode/17/107.shtml

Published by Medtext, Inc., Willowbrook, IL, 630-325-3276
E-mail to: editor (at sign) hdcn.net